Literature DB >> 30272836

Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008).

Heather Greenlee1,2, Danika L Lew3, Dawn L Hershman1,4, Vicky A Newman5, Lisa Hansen6, Sheri J Hartman5,7, Judith Korner4, Zaixing Shi1, Christine L Sardo Molmenti1, Antoine Sayegh8, Lou Fehrenbacher9, Shelly Lo10, Jennifer Klemp11, Kristine Rinn12, John M Robertson13, Joseph Unger3, Julie Gralow14, Kathy Albain10, Robert Krouse15, Carol Fabian11.   

Abstract

OBJECTIVE: This study aimed to test the feasibility of a 12-month weight loss intervention using telephone-based counseling plus community-situated physical activity (PA) in female breast cancer (BC) and colorectal cancer (CRC) survivors.
METHODS: This multisite cooperative group study enrolled sedentary, female, postmenopausal BC and CRC survivors with BMI ≥ 25 kg/m2 to receive 12-month fitness center memberships and telephone counseling encouraging 150 min/wk of PA and a 500-kcal/ddecrease in energy intake. Feasibility criteria included accrual, adherence, and retention. Target weight loss was ≥ 5%.
RESULTS: Among 25 BC survivors, median baseline BMI was 37.2 (range: 27.7-54.6), accrual occurred in 10 months, 60% and 28% met diet and exercise goals, 80% provided 12-month measures, and average weight loss was 7.6% (95% CI: -3.9%, 19.2%). Among 23 CRC survivors, median BMI was 31.8 (range: 26.4-48.7), accrual occurred in 24 months, 61% and 17% met diet and exercise goals, 87% provided measures, and average weight loss was 2.5% (95% CI: -8.2%, 13.3%).
CONCLUSIONS: It is feasible to recruit and retain BC survivors in a cooperative group diet and PA weight loss trial. BC survivors achieved clinically meaningful weight loss but did not meet a priori adherence goals. In CRC survivors, recruitment was more difficult, and the intervention was less effective.
© 2018 The Obesity Society.

Entities:  

Mesh:

Year:  2018        PMID: 30272836      PMCID: PMC6611675          DOI: 10.1002/oby.22269

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  27 in total

1.  Postdiagnosis change in bodyweight and survival after breast cancer diagnosis.

Authors:  Patrick T Bradshaw; Joseph G Ibrahim; June Stevens; Rebecca Cleveland; Page E Abrahamson; Jessie A Satia; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

2.  Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors.

Authors:  Wendy Demark-Wahnefried; Miriam C Morey; Richard Sloane; Denise C Snyder; Paige E Miller; Terryl J Hartman; Harvey J Cohen
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

3.  Weight, weight gain, and survival after breast cancer diagnosis.

Authors:  Candyce H Kroenke; Wendy Y Chen; Bernard Rosner; Michelle D Holmes
Journal:  J Clin Oncol       Date:  2005-01-31       Impact factor: 44.544

4.  Randomized controlled trial of weight training and lymphedema in breast cancer survivors.

Authors:  Rehana L Ahmed; William Thomas; Douglas Yee; Kathryn H Schmitz
Journal:  J Clin Oncol       Date:  2006-05-15       Impact factor: 44.544

5.  Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.

Authors:  James J Dignam; Blase N Polite; Greg Yothers; Peter Raich; Linda Colangelo; Michael J O'Connell; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

6.  Weight change and survival after breast cancer in the after breast cancer pooling project.

Authors:  Bette J Caan; Marilyn L Kwan; Xiao Ou Shu; John P Pierce; Ruth E Patterson; Sarah J Nechuta; Elizabeth M Poole; Candyce H Kroenke; Erin K Weltzien; Shirley W Flatt; Charles P Quesenberry; Michelle D Holmes; Wendy Y Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-13       Impact factor: 4.254

7.  Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial.

Authors:  Pamela J Goodwin; Roanne J Segal; Michael Vallis; Jennifer A Ligibel; Gregory R Pond; André Robidoux; George L Blackburn; Brian Findlay; Julie R Gralow; Som Mukherjee; Mark Levine; Kathleen I Pritchard
Journal:  J Clin Oncol       Date:  2014-06-16       Impact factor: 44.544

8.  Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.

Authors:  Cheryl L Rock; Shirley W Flatt; Tim E Byers; Graham A Colditz; Wendy Demark-Wahnefried; Patricia A Ganz; Kathleen Y Wolin; Anthony Elias; Helen Krontiras; Jingxia Liu; Michael Naughton; Bilgé Pakiz; Barbara A Parker; Rebecca L Sedjo; Holly Wyatt
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

9.  Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.

Authors:  Bette J Caan; Marilyn L Kwan; Georgina Hartzell; Adrienne Castillo; Martha L Slattery; Barbara Sternfeld; Erin Weltzien
Journal:  Cancer Causes Control       Date:  2008-08-28       Impact factor: 2.506

10.  Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.

Authors:  Peter T Campbell; Christina C Newton; Polly A Newcomb; Amanda I Phipps; Dennis J Ahnen; John A Baron; Daniel D Buchanan; Graham Casey; Sean P Cleary; Michelle Cotterchio; Alton B Farris; Jane C Figueiredo; Steven Gallinger; Roger C Green; Robert W Haile; John L Hopper; Mark A Jenkins; Loïc Le Marchand; Karen W Makar; John R McLaughlin; John D Potter; Andrew G Renehan; Frank A Sinicrope; Stephen N Thibodeau; Cornelia M Ulrich; Aung Ko Win; Noralane M Lindor; Paul J Limburg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-02       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.